Abstract
The subthalamic nucleus (STN) is successfully used as a surgical target for deep brain stimulation in the treatment of movement disorders. Interestingly, the internal structure of the STN is still incompletely understood. The objective of the present study was to investigate three-dimensional (3D) immunoreactivity patterns for 12 individual protein markers for GABA-ergic, serotonergic, dopaminergic as well as glutamatergic signaling. We analyzed the immunoreactivity using optical densities and created a 3D reconstruction of seven postmortem human STNs. Quantitative modeling of the reconstructed 3D immunoreactivity patterns revealed that the applied protein markers show a gradient distribution in the STN. These gradients were predominantly organized along the ventromedial to dorsolateral axis of the STN. The results are of particular interest in view of the theoretical underpinning for surgical targeting, which is based on a tripartite distribution of cognitive, limbic and motor function in the STN.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Among the over 450 subcortical structures of the human brain is the subthalamic nucleus (STN), which is involved in many functions, ranging from speeded decision-making to emotional regulation (Frank 2006; Herculano-Houzel 2012; Alkemade 2013; Péron et al. 2013; Aron et al. 2016; Forstmann et al. 2017), the STN is of particular interest as a target for deep brain stimulation (DBS) to alleviate symptoms in a variety of movement disorders including Parkinson’s disease (PD) (Temel et al. 2005).
The internal structure of the human STN is a topic of ongoing discussion and consistency between empirical studies is limited (Keuken et al. 2012; Alkemade et al. 2015). A prominent model of the internal structure of the STN in the scientific literature is the tripartite model, which divides the STN in a limbic medial tip, a ventromedial cognitive area, and a dorsolateral motor area (Temel et al. 2005). The level of anatomical separation between the subdivisions of the STN is unknown, and findings vary based on the applied research technique (Alkemade and Forstmann 2014; Lambert et al. 2015). The principle of functional segregation offers a theoretical framework for defining subdivisions in the STN at the cellular level. According to this principle, neuronal cell types move apart during development, depending on the specializations they acquire (Arendt 2008). During this process, they form distinct neuronal populations, with potentially distinct functions, as reflected by their individual molecular fingerprint. Immunocytochemical approaches in postmortem tissues allow the identification of neuronal subpopulations, and thereby potentially subdivisions within the STN (Forstmann et al. 2017).
The availability of detailed information on the immunocytochemical characteristics of the human STN is generally of high quality, but only a small number of detailed studies on serotonin (5HT), and its transporter (SERT), and on PARV and CALR expression report on a topographical organization within the STN (Mori et al. 1985; Parent et al. 1996, 2011; Augood et al. 1999). Additionally, studies on the human and nonhuman primate STN have revealed the expression of glutamatergic, GABA-ergic, dopaminergic, serotonergic as well as endogenous opioid markers, in addition to calcium-binding proteins (Kultas-Ilinsky et al. 1998; Augood et al. 1999, 2000; Hedreen 1999; Charara et al. 2000; Kuwajima et al. 2004; Levesque and Parent 2005; Aron and Poldrack 2006; Isoda and Hikosaka 2008). A number of the immunocytochemical studies available do not report specifically on distribution patterns within the human STN (Nauta and Cole 1978; Mori et al. 1985; Kultas-Ilinsky et al. 1998; Augood et al. 1999, 2000; Hedreen 1999; Charara et al. 2000; Hurd et al. 2001; Kuwajima et al. 2004; Levesque and Parent 2005; Aubert et al. 2007; Parent et al. 2011), and classical immunocytochemical studies generally are descriptive in nature. Here we set out to investigate the three-dimensional (3D) functional microscopic neuroanatomy of the human STN in a systematic manner, and allowing quantitative stereological analyses of the data. We have created 3D reconstructions of immunocytochemical staining patterns for quantitative comparisons, which allows us to assess the internal structure of the STN at the cellular level. Our results show a clear anatomical organization within the STN, and consistency across subjects. Our findings indicate that there are reoccurring patterns in the distribution of the individual immunocytochemical markers.
Results
We obtained ten formalin-fixed tissue blocks containing the left STN from clinically non-demented donors via the Netherlands Brain Bank (www.brainbank.nl). Right STNs were used for neuropathological assessments and were, therefore, not available for our research. Clinicopathological data are presented in Table 1.
Twelve primary antibodies were used for immunocytochemical studies of the STN. Antibody selection was based on the ability to label general cell features or major neurotransmitter systems, and reports on their expression in the STN (see “Methods”). Consecutive sections containing the STN were stained for (1) Neurofilament H (SMI-32), which showed clear labeling of the neuronal cell bodies. Additionally, weak fiber staining was present, and occasionally, long thin fibers were stained in the dorsolateral part of the STN; (2) synaptophysin (SYN), which showed punctate staining scattered throughout the nucleus, as well as neuronal somata surrounded by puncta. Additionally, the punctate staining extended beyond the dorsolateral tip of the nucleus in the shape of a cap. (3) Myelin basic protein (MBP) revealed clear labeling of myelin sheaths throughout the nucleus, (4) tyrosine hydroxylase (TH), which was observed in thick long, and thin punctate fibers. (5) Vesicular glutamate transporter 1 (VGLUT1) showed punctate fiber labeling. Increased density was present at the borders of the nucleus. (6) Glutamate decarboxylase 65/67 (GAD65/67) showed moderate fiber terminal staining; positive neurons were observed only occasionally. Additionally, presynaptic boutons were observed extending beyond the dorsolateral border of the STN, appearing as a cap on the dorsolateral tip of the nucleus. (7) GABA-A receptor subunit alpha 3 (GABRA3) showed predominant neuronal staining, in addition to punctate fiber staining. (8) Serotonin transporter (SERT), showed clear fiber labeling. (9) Parvalbumin (PARV) revealed clear labeling of cell bodies, as well as diffuse labeling of fibers; (10) calretinin (CALR) labeled both cell bodies and fibers. (11) Transferrin (TF) labeling was present in oligodendrocytes, as well as numerous blood vessels. The oligodendrocytes displayed a clear rounded shape and cytoplasmic staining. Positive neurons were detected frequently while few fibers were also present. Transferrin staining showed substantial background staining, which fits with transferrin labeling in the extracellular matrix. (12) Ferritin (FERR) staining revealed numerous positive oligodendrocytes, as well as weaker punctate staining. For illustrations, see Fig. 1 and supplementary material 1.
The antibodies include markers for the principal excitatory glutamatergic system, the principle inhibitory GABA-ergic system as well as other major neurotransmitter systems such as dopamine and serotonin. A more extensive overview of the characteristics of the antibodies is presented in “Methods”. Immunoreactivity was visually inspected and present for all proteins in all tested tissue specimens, and staining intensity showed substantial interindividual variation, which is in line with previous publications (Alkemade et al. 2012; Borgers et al. 2014). Digital images were created and shape information was used to perform linear transformations for registration to the corresponding block face images. Additionally, manual outlines of the STN were created by two independent raters on PARV and SMI32 sections to define the location and outline of each individual STN. These STN outlines and the thresholded staining results allowed the reconstruction of 3D densitometric data (arbitrary units) into block face space in seven tissue specimens as illustrated in Fig. 2. For three other blocks, 3D reconstructions were not further analyzed, due to poor quality as a result of distortions and tissue damage. Visual inspection showed protein marker expression throughout the entire STN, for each marker, with clear local intensity differences for each marker.
To investigate the consistency of the immunoreactivity patterns across specimens, each individual 3D reconstruction of an individual staining pattern was rasterized into 3 × 3 × 3=27 sectors of equal volume along the rostrocaudal axis, and the dorsolateral–ventromedial, and its orthogonal axis. For each sector and protein marker, the mean staining intensity was tested against the mean of the sectors. For 10 out of 12 markers, a consistent inhomogeneous immunoreactivity pattern was identified in one or more sector using one-sample t tests, thresholded at a false discovery rate of q < 0.05.
We subsequently investigated the immunoreactivity patterns in more detail, and tested whether they were best described using a gradient model or using a tripartite model. We rasterized the STN in 1000 voxels in the dimensions identified with the PCA analysis described above (10 voxels in each direction). We then fit four generalized linear models (GLMs) with negative binomially distributed errors for each specimen and protein marker. These GLMs describe the expression in each voxel as a function of location in space along the PCA dimensions. Model A assumes no change across space (homogenous immunoreactivity):
in which y is the observed immunoreactivity, \(\lambda_{0}\) an intercept, and α the gamma distribution parameter that is assumed to underlie the rate distribution of a Poisson process. Model B assumes that the change in expression is linear across space:
where x1–x3 are the voxels’ location along the rostrocaudal, the dorsomedial–ventrolateral, and its orthogonal axes, respectively, and \(\lambda_{1 - 3}\) the corresponding weights. Model C assumes three subdivisions separated by abrupt boundaries:
where each voxel location is projected onto a new axis p, which defines the axis along which the borders \(\tau_{1 - 2}\) are located. Finally, Model D assumes a gradient of non-linear changes:
such that changes across space are described by a sigmoidal function with smoothness parameter \(\kappa\). Variables used are y = stain intensity, x1, 2, 3 = voxel locations along the three axes, p = projection axis, ||p|| = length of projection axis, d1/d2 = dummy variables.
The Bayesian Information Criterion (Schwarz 1978; Wagenmakers and Farrell 2004) was used to compare the quality of fit of the four GLMs. The BIC provides a measure of the quality of model fit penalized for model complexity to provide a quantification of parsimony. The results of the model comparison are shown in Table 2. Model B (linear gradient) provided the best fit in 61.9% of the specimen/protein marker combinations, and is the overall preferred model as evidenced by the highest mean weighted BIC. Non-linear gradient Model D was preferred in 29.76% of the cases, and the tripartite model provides the best description of the data for the remaining 8.33% of the specimen/protein marker combinations (Table 2).
Figure 3 illustrates the overall quality of the fit of Model B. For each specimen, individual immunoreactivity data and model predictions were normalized to mean 0 and standard deviation 1. Model B, which described a linear gradient, was able to capture the global patterns in expression across space best for protein markers CALR, GABRA3, GAD6567, SERT, SMI32, SYN, TH, and VGLUT1. MBP, FER, PARV, and TRANSF show less consistency across specimens and/or highly non-linear patterns across space (e.g., local spheres of expression, c.f. PARV).
Discussion
In the present study, we provide spatial detail and 3D information that allow us to move beyond descriptive accounts of the anatomy of the human STN. The results confirm that the STN is not a homogenous nucleus, nor does the organization of the STN support of the existence of subdivisions as defined by clustered neuronal populations with limited border zones.
An inherent limitation of postmortem studies is a bias towards old age, as well as strong variation in antemortem disease and cause of death. Since we collected the tissue from clinically non-demented controls in a prospective fashion, we did not select donors with comparable disease state, as described previously (Alkemade et al. 2003, 2005b). By chance, we included three female centenarians in our studies. In view of these limitations, we cannot draw any meaningful conclusions on potential effects of factors such as age, sex or disease state. We would like to stress that immunoreactivity is determined by protein expression, as well as the staining procedure. Therefore, no meaningful conclusions can be drawn from comparisons across antibodies within the current studies or from comparisons to reports on the abundance of immunoreactivity across species in literature. All comparisons described here are, therefore, performed exclusively within and not across the individual markers. Our data are in agreement with earlier results on the human and nonhuman primate STN (Nauta and Cole 1978; Mori et al. 1985; Kultas-Ilinsky et al. 1998; Augood et al. 1999, 2000; Hedreen 1999; Charara et al. 2000; Hurd et al. 2001; Kuwajima et al. 2004; Levesque and Parent 2005; Aubert et al. 2007; Parent et al. 2011), and allow us to speculate further on the existence of functional subdivisions in the STN. Distinct PARV and CALR distributions suggest local differences in intracellular calcium dynamics in the STN, and highest immunoreactivity indicative of GABA-ergic signaling was located in the ventromedial part of the anterior half of the nucleus. This did not coincide with the most intense glutamatergic immunoreactivity, which was located in the dorsocaudal extent of the STN. It is important to note that both markers for GABA- and glutamatergic signaling were expressed throughout the STN. The variability in intensity distributions between the 12 individual markers points towards a complex STN organization, indicating that the tripartite hypothesis of the STN represents an oversimplification of its internal structure.
Our statistical modeling reveals consistent gradients in the immunoreactivity patterns throughout the human STN. Interpreting these findings within the framework of functional segregation, the spatial segregation of individual cell populations within the STN during development appears to occur only to some extent at best, resulting in incomplete functional segregation within the STN. Small nonhuman primate studies show that neurons located in the dorsolateral part of the STN are connected to the globus pallidus externa, whereas neurons connected to the globus pallidus interna, substantia nigra pars reticulata, and caudate nucleus are large, although not exclusively confined to the ventromedial parts of the STN (Nauta and Cole 1978; Smith et al. 1990). In addition, neurons projecting to the ventral globus pallidus are located in the medial STN (Nauta and Cole 1978; Smith et al. 1990). Thorough tracing studies in nonhuman primates have revealed a clear topological organization of connectivity in the STN, but tracing techniques inherently lead to an underestimation of the quantity and distribution of projections in the STN (Alkemade 2013; Haynes and Haber 2013).
In vivo imaging studies, as well as clinical observations, provide some support for zonation within the STN [see (Alkemade et al. 2015) for review], although caution should be applied when interpreting these data, since the limited anatomical detail does not allow reliable assessment of the level of anatomical segregation between potential functional subdivisions. Here, we have studied that the internal structure of the STN within the framework of functional segregation, and the complex neuroanatomical structure, including the strong overlap of the distribution patterns of the immunocytochemical markers indicates that there is little evidence for anatomical segregation. We, therefore, conclude that the distribution of immunoreactivity as described here do not align with proposed functional subdivisions (Keuken et al. 2012; Alkemade and Forstmann 2014), and is in support of limited local function specialization. It is difficult to predict the importance of the observed topographical variations for the mechanism underlying DBS. STN electrodes inserted to treat a number of motor disorders are aimed at the dorsolateral part of the STN (Greenhouse et al. 2013). In line with the results of Haynes and Haber (Haynes and Haber 2013), who showed significant overlap in projection patterns within the primate STN, we found that none of the tested markers was confined to the dorsolateral STN, and we found no evidence for anatomical borders with clear subdivisions.
Methods
Tissue processing
All brain tissues were collected within a 4-year period with a < 8-h postmortem interval before brain autopsy. Tissues were obtained in accordance with BrainNet Europe’s Code of Conduct for brain banking (Klioueva et al. 2015). Dissection of the STN was performed at the time of autopsy, and all tissue specimens were subjected to the same tissue processing procedure. Tissue blocks were dehydrated and paraffin embedded. Block face imaging was performed while cutting serial coronal sections (6 µm) and images were realigned for reconstruction purposes. Sections were systematically sampled with 300-µm intervals, stained, and digitally imaged to produce a 3D reconstruction of the staining profiles in block face space.
Tissue was fixated for approximately 8 weeks in 10% formalin (10× V/V). After initial formalin fixation, tissues were transferred to phosphate-buffered saline [PBS (pH ~ 6.6–7.0): 145 mM NaCl, 9 mM disodium phosphate (Na2HPO4 cat. no. 71640, Sigma-Aldrich, St. Louis, MO, USA), 2 mM sodium phosphate (NaH2PO4·H2O, cat. no. S9638, Sigma-Aldrich, St. Louis, MO, USA)] containing 0.02% sodium azide to prevent fungal growth until further processing. Following dehydration, tissues were embedded in paraffin, after which 6-µm-thick serial coronal sections were cut covering the rostrocaudal axis of the STN. While processing, block face imaging was performed (at an interval of 50 sections), which provides an intermediate step crucial for 3D reconstructions. This was done using a camera mounted in front of the tissue blocks.
At the block face imaging level, sections were mounted on Menzel-Gläser Superfrost plus object slides (Cat. no. J1800AMNZ, Thermo Scientific, Braunschweig, Germany) and stained with thionine (Thionine acetate: cat. no. 1.15929.0025, Merck, Darmstadt, Germany) for anatomical orientation. Sections were stained at 300-µm intervals, which allowed us to identify the borders of the STN using a light microscope. At each level, consecutive sections containing the STN were mounted for immunocytochemical staining of neurofilament H (SMI-32), synaptophysin (SYN), tyrosine hydroxylase (TH), vesicular glutamate transporter 1 (VGLUT1), glutamate decarboxylase 65/67 (GAD65/67), GABA-A receptor subunit alpha 3 (GABRA3), serotonin transporter (SERT), parvalbumin (PARV), calretinin (CALR), transferrin (TRANSF), and ferritin (FERR) (see Table 3).
Each section was stained using a single antibody. In short, paraffin was cleared from the slides using xylene and tissues were rehydrated using a graded series of alcohols. After rinsing in distilled water, antigen retrieval was performed using heat treatment (Shi et al. 1997), and pre-incubation was performed if appropriate. Subsequent incubation in the primary antibody was performed overnight in a humidified chamber in Supermix [(SUMI): TBS containing 0.25% gelatin (cat. no. 1.04078.1000, Merck, Darmstadt, Germany) and 0.5% Triton X-100 (cat.no. X100, Sigma-Aldrich, St. Louis, MO, USA)]. After rinsing in Tris-buffered saline [(TBS): 150 mM NaCl (cat. no. 1.06404.1000, Merck, Darmstadt, Germany), 50 mM Tris–HCl, pH 7.6 (Trizma cat. no. T1503, Sigma-Aldrich, St. Louis, MO, USA)], sections were incubated in an appropriate biotinylated secondary antibody (Vector laboratories Inc., Burlingame, CA, USA), followed by incubation in avidin-biotinylated complex (VECTASTAIN ABC Kit: cat. no. PK-6100, Vector laboratories Inc., Burlingame, CA, USA) and visualization of the staining using diaminobenzidine amplified with nickel ammonium sulphate [DAB: cat. no. D5637, Sigma-Aldrich, St. Louis, MO, USA; Ammonium nickel (II) sulfate: BDH Chemicals, UK] as a chromogen resulting in an intense purple precipitate as described previously (Alkemade et al. 2005a, c, 2012; Borgers et al. 2013). Sections were cover slipped using Entellan (Cat. no. 1.0791.0500, Merck, Darmstadt, Germany).
Image processing
Block face images were restacked using image J (1.48 V), Stackreg (Thévenaz et al. 1998). Tissue borders were manually outlined in the block face image since the more caudal tissue was visible in the paraffin resulting in limited contrast that did not allow reliable automatic parcellation of the tissue in the field of view.
All stained sections were digitally imaged using a slide scanner (Ventana iScan HT, Roche). The appropriate image was selected and extracted from the BigTiff format, and the image was adjusted to allow registration of the protein markers to the appropriate block face images. Image conversion was performed to exclude contrast in the tissue and to allow registration based on shape of the tissue. This was done because the contrast information obtained from the block face image was substantially different from that obtained from staining. Images were registered using a scaled rotation, followed by an affine transformation. Transformation matrices were saved. All transformations were visually inspected, and if the results were unsatisfactory, as evidenced by clear jumps of the sections within the reconstructed STN structure, images were registered using a rigid body transformation followed by an affine registration. If registration results were still deemed to be insufficient, images were discarded. As a result, overall registration of #12-062, 12-082, and 12-104 was judged insufficient, and these specimens were excluded from further analyses.
Thresholding of the staining
A histogram-based thresholding procedure was applied to remove background signal from the immunocytochemistry procedure on the red channel of the stained images in ImageJ, by creating a RGB-stack, followed by the default thresholding procedure implemented in ImageJ, similar to previous reports (Alkemade et al. 2012; Borgers et al. 2013; Ten Kulve et al. 2016). Threshold settings were determined experimentally [CALR (0, 95), FER (0, 127), GABRA (0, 134), GAD6567 (51, 112), MBP (0, 130), PARV (41, 133), SERT (0, 165), SMI (0, 156), SYN (0, 162), TRANSF (0, 110), TH (0, 155), VGLUT1 (0, 140)]. The thresholded images were converted using the binary mask functions to which subsequently the scaled rotation and affine transformation matrices, and, if appropriate, the rigid body and affine transformation matrices were applied (see Fig. 2 for an example). Two independent raters delineated the STN over the entire rostrocaudal axis of the STN using PARV and SMI32 images. The area included in the STN in a minimum of three masks was used for further analyses.
Quantitative analyses of immunoreactivity
Immunocytochemical were brought to individual block face space for each specimen. These images had a resolution of 0.014 mm isotropic in the cutting plane, and 0.3 mm between adjacent slices. For the immunocytochemical images, the thresholded and transformed images constructed using imageJ were analyzed. These images were smoothed with a Gaussian kernel with a full-width half maximum (FWHM) of 0.3 mm (Szeliski 2010; de Hollander et al. 2014). This smoothing procedure was performed to (1) increase signal-to-noise ratio and (2) focus the analyses on topological patterns in the order of 0.1–1 mm, rather than patterns in structures much smaller than the STN. To ensure that image intensities outside the STN mask were not included in the analyses, the smoothing kernel was truncated outside the STN mask and normalized.
Consistency of immunoreactivity patterns
To analyze the data of seven different STN specimens in a common space, they were rasterized in 27 sectors. Sectors were created by defining and dividing three axes in the STN into three equal parts. The first axis was defined by the rostrocaudal cutting plane. The two other axes were defined by a principal component analysis (Bishop 2006) on the 2D coordinates over all slices. The resulting axes were visually inspected and were consistently identified as a main dorsolateral → ventromedial axis and a mediodorsal → ventromedial axis.
For each individual specimen, sectors were subjected to PCA analyses to test whether specific sectors showed altered immunoreactivity. For each specimen and antibody, the 27 sectors were demeaned and standardized, setting their mean at 0 and their standard deviation at 1. Subsequently, per sector, a one-sample t test was performed over the 7 STN specimens. Results underwent a false discovery rate correction to account for multiple comparisons. Significant t values indicated altered local expression levels.
STN specimens were then rasterized into 1000 sectors. The immunoreactivity in the identified sectors was entered as a dependent variable in a set of general linear models (GLMs). As an error function, the negative binomial was used to account for the observed overdispersion. The negative binomial describes a Poisson variable with a rate that is gamma distributed with parameter α.
Models were fit using maximum likelihood estimation. Since maximum likelihood estimation is susceptible to outlying data points, sectors with extremely high intensity (defined here as five times the interquartile range above the median after a log-transformation) were excluded from these analyses (0.07% of all data points). Optimization was performed using differential evolution (Storn and Price 1997) with population sizes set to 20 times the number of parameters in a model, and up to 5000 iterations. Subsequently, the parameters were refined using least-squares optimization. Both optimization algorithms were implemented in Python library Scipy [version 1.2.0 (Jones E, Oliphant E, Peterson P)]. Parameter optimization bounds were set between [− 15, 200] for \(\lambda_{0}\) (all models) and \(\lambda_{1 - 2}\) (Models C–D); [− 2, 2] for \(\lambda_{1 - 3}\) (Model B); [0, 1] for \(\beta_{1 - 2}\) (Models 3–4); [0.2, 0.6] for \(\tau_{1}\) and [0.4, 0.8] for \(\tau_{1}\); [1, 1×1020] for \(\kappa\) (Model D) and α (all models). Parameters \(\tau_{1 - 2}\) were constrained to ensure that each fit subdivision spans at least 20% of the length of the projection axis p, to prevent the optimization routine from identifying very small, anatomically implausible subdivisions.
The Bayesian information criterion [BIC (Schwarz 1978; Wagenmakers and Farrell 2004)] was used for model comparison. It is defined as \({\text{BIC}} = - 2\log \left( L \right) - k\log \left( n \right)\), where L is the likelihood of the data under the model, k the number of parameters of the model, and n the number of data points. Lower BIC values indicate a more parsimonious trade-off between quality of fit and model complexity. To compare BICs across protein markers and specimens, the weighted BIC (wBIC) of each model i was used:
where \(\Delta_{i} \left( {\text{BIC}} \right) = {\text{BIC}}_{i} - \hbox{min} \left( {\text{BIC}} \right)\). The wBIC values can be interpreted as the probability a model is the data-generating model under the assumption that the data-generating model is among the models under consideration (Wagenmakers and Farrell 2004). Higher wBIC values thus indicate more evidence for each model.
Data and computer code availability
The 10 × 10 × 10 grid data corresponding to the 1000 sectors that were analyzed are available via https://figshare.com/s/aee5a09da245058504a9.
Computer code is available via: https://github.com/StevenM1/histochemical_mri_stn and https://github.com/StevenM1/pystain.
References
Addis RC, Hsu FC, Wright RL et al (2011) Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One 6:e28719. https://doi.org/10.1371/journal.pone.0028719
Alkemade A (2013) Subdivisions and anatomical boundaries of the subthalamic nucleus. J Neurosci 33:9233–9234. https://doi.org/10.1523/JNEUROSCI.1266-13.2013
Alkemade A, Forstmann BU (2014) Do we need to revise the tripartite subdivision hypothesis of the human subthalamic nucleus (STN)? Neuroimage 95:326–329. https://doi.org/10.1016/j.neuroimage.2014.03.010
Alkemade A, Unmehopa UA, Brouwer JP et al (2003) Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression. Mol Psychiatry. https://doi.org/10.1038/sj.mp.4001364
Alkemade A, Friesema EC, Unmehopa UA et al (2005a) Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2004-2567
Alkemade A, Unmehopa UA, Wiersinga WM et al (2005b) Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab 90:323–327. https://doi.org/10.1210/jc.2004-1430
Alkemade A, Vuijst CL, Unmehopa UA et al (2005c) Thyroid hormone receptor expression in the human hypothalamus and anterior pituitary. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2004-0474
Alkemade A, Yi CX, Pei L et al (2012) AgRP and NPY expression in the human hypothalamic infundibular nucleus correlate with body mass index, whereas changes in aMSH are related to type 2 diabetes. J Clin Endocrinol Metab 97:E925–E933
Alkemade A, Schnitzler A, Forstmann BU (2015) Topographic organization of the human and non-human primate subthalamic nucleus. Brain Struct Funct 220:3075–3086. https://doi.org/10.1007/s00429-015-1047-2
Andrioli A, Alonso-Nanclares L, Arellano JI, DeFelipe J (2007) Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience 149:131–143. https://doi.org/10.1016/j.neuroscience.2007.07.029
Arendt D (2008) The evolution of cell types in animals: emerging principles from molecular studies. Nat Rev Genet 9:868–882. https://doi.org/10.1038/nrg2416
Aron AR, Poldrack RA (2006) Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J Neurosci 26:2424–2433. https://doi.org/10.1523/JNEUROSCI.4682-05.2006
Aron AR, Herz DM, Brown P et al (2016) Frontosubthalamic circuits for control of action and cognition. J Neurosci 36:11489–11495
Aubert I, Guigoni C, Li Q et al (2007) Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in l-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry 61:836–844. https://doi.org/10.1016/j.biopsych.2006.06.038
Augood SJ, Waldvogel HJ, Munkle MC et al (1999) Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus. Neuroscience 88:521–534
Augood SJ, Hollingsworth ZR, Standaert DG et al (2000) Localization of dopaminergic markers in the human subthalamic nucleus. J Comp Neurol 421:247–255
Bar-Peled O, Ben-Hur H, Biegon A et al (1997) Distribution of glutamate transporter subtypes during human brain development. J Neurochem 69:2571–2580
Bauman AL, Apparsundaram S, Ramamoorthy S et al (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571–7578
Bengel D, Murphy DL, Andrews AM et al (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol 53:649–655
Bishop CM (2006) Pattern recognition and machine learning. Springer, New York
Borgers AJ, Fliers E, Siljee JE et al (2013) Arginine vasopressin immunoreactivity is decreased in the hypothalamic suprachiasmatic nucleus of subjects with suprasellar tumors. Brain Pathol. https://doi.org/10.1111/bpa.12016
Borgers AJ, Koopman KE, Bisschop PH et al (2014) Decreased serotonin transporter immunoreactivity in the human hypothalamic infundibular nucleus of overweight subjects. Front Neurosci. https://doi.org/10.3389/fnins.2014.00106
Brownlees J, Yates A, Bajaj NP et al (2000) Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113(Pt 3):401–407
Caspary DM, Hughes LF, Ling LL (2013) Age-related GABAA receptor changes in rat auditory cortex. Neurobiol Aging 34:1486–1496. https://doi.org/10.1016/j.neurobiolaging.2012.11.009
Charara A, Heilman TC, Levey AI, Smith Y (2000) Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys. Neuroscience 95:127–140
de Hollander G, Keuken MC, Bazin PL et al (2014) A gradual increase of iron toward the medial-inferior tip of the subthalamic nucleus. Hum Brain Mapp 35:4440–4449. https://doi.org/10.1002/hbm.22485
Dobi A, Margolis EB, Wang HL et al (2010) Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30:218–229. https://doi.org/10.1523/JNEUROSCI.3884-09.2010
Duan W, Zhang R, Guo Y et al (2009) Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. Vitro Cell Dev Biol Anim 45:388–397. https://doi.org/10.1007/s11626-009-9194-5
Dubelaar EJ, Verwer RW, Hofman MA et al (2004) ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 63:159–169
Eftekhari S, Edvinsson L (2011) Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 12:112. https://doi.org/10.1186/1471-2202-12-112
Erkut ZA, Hofman MA, Ravid R, Swaab DF (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 62:27–33
Fernyhough P, Gallagher A, Averill SA et al (1999) Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48:881–889
Forstmann BU, de Hollander G, van Maanen L et al (2017) Towards a mechanistic understanding of the human subcortex. Nat Rev Neurosci 18:57–65. https://doi.org/10.1038/nrn.2016.163
Frank MJ (2006) Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw 19:1120–1136. https://doi.org/10.1016/j.neunet.2006.03.006
Fronczek R, Lammers GJ, Balesar R et al (2005) The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab 90:5466–5470. https://doi.org/10.1210/jc.2005-0296
Fuentealba P, Klausberger T, Karayannis T et al (2010) Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J Neurosci 30:1595–1609. https://doi.org/10.1523/JNEUROSCI.4199-09.2010
Gottschall PE, Ajmo JM, Eakin AK et al (2010) Panel of synaptic protein ELISAs for evaluating neurological phenotype. Exp Brain Res 201:885–893. https://doi.org/10.1007/s00221-010-2182-x
Greenhouse I, Gould S, Houser M, Aron AR (2013) Stimulation of contacts in ventral but not dorsal subthalamic nucleus normalizes response switching in Parkinson’s disease. Neuropsychologia 51:1302–1309. https://doi.org/10.1016/j.neuropsychologia.2013.03.008
Gross A, Sims RE, Swinny JD et al (2011) Differential localization of GABAA receptor subunits in relation to rat striatopallidal and pallidopallidal synapses. Eur J Neurosci 33:868–878. https://doi.org/10.1111/j.1460-9568.2010.07552.x
Gveric D, Hanemaaijer R, Newcombe J et al (2001) Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain 124:1978–1988
Hara A, Aoki H, Taguchi A et al (2008) Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter. Stem Cells Dev 17:619–627. https://doi.org/10.1089/scd.2007.0235
Haynes WIA, Haber SN (2013) The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for Basal Ganglia models and deep brain stimulation. J Neurosci 33:4804–4814. https://doi.org/10.1523/JNEUROSCI.4674-12.2013
Hedou G, Chasserot-Golaz S, Kemmel V et al (2000) Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum. J Comp Neurol 426:549–560
Hedreen JC (1999) Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 409:400–410
Henry LK, Adkins EM, Han Q, Blakely RD (2003) Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J Biol Chem 278:37052–37063. https://doi.org/10.1074/jbc.M305514200
Herculano-Houzel S (2012) The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost. Proc Natl Acad Sci USA 109(Suppl):10661–10668. https://doi.org/10.1073/pnas.1201895109
Huang L, Garcia I, Jen HI, Arenkiel BR (2013) Reciprocal connectivity between mitral cells and external plexiform layer interneurons in the mouse olfactory bulb. Front Neural Circuits 7:32. https://doi.org/10.3389/fncir.2013.00032
Hurd YL, Suzuki M, Sedvall GC (2001) D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat 22:127–137
Isoda M, Hikosaka O (2008) Role for subthalamic nucleus neurons in switching from automatic to controlled eye movement. J Neurosci 28:7209–7218. https://doi.org/10.1523/JNEUROSCI.0487-08.2008
Jablonska B, Scafidi J, Aguirre A et al (2012) Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-mediated p27Kip1 expression. J Neurosci 32:14775–14793. https://doi.org/10.1523/JNEUROSCI.2060-12.2012
Jones E, Oliphant E, Peterson P et al (2001) SciPy Open Source Sci Tools Python. www.scipy.org
Kanaan NM, Kordower JH, Collier TJ (2007) Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J Comp Neurol 502:683–700. https://doi.org/10.1002/cne.21333
Kempf C, Staudt T, Bingen P et al (2013) Tissue multicolor STED nanoscopy of presynaptic proteins in the calyx of held. PLoS One 8:e62893. https://doi.org/10.1371/journal.pone.0062893
Keuken MC, Uylings HB, Geyer S et al (2012) Are there three subdivisions in the primate subthalamic nucleus? Front Neuroanat 6:14. https://doi.org/10.3389/fnana.2012.00014
Kirvell SL, Esiri M, Francis PT (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer’s disease. J Neurochem 98:939–950. https://doi.org/10.1111/j.1471-4159.2006.03935.x
Klioueva NM, Rademaker MC, Dexter DT et al (2015) BrainNet Europe’s Code of Conduct for brain banking. J Neural Transm 122:937–940. https://doi.org/10.1007/s00702-014-1353-5
Kultas-Ilinsky K, Leontiev V, Whiting PJ (1998) Expression of 10 GABA(A) receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry. Neuroscience 85:179–204
Kuwajima M, Hall RA, Aiba A, Smith Y (2004) Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus. J Comp Neurol 474:589–602. https://doi.org/10.1002/cne.20158
Lambert C, Zrinzo L, Nagy Z et al (2015) Do we need to revise the tripartite subdivision hypothesis of the human subthalamic nucleus (STN)? Response to Alkemade and Forstmann. Neuroimage. https://doi.org/10.1016/j.neuroimage.2015.01.038
Lancaster MA, Renner M, Martin CA et al (2013) Cerebral organoids model human brain development and microcephaly. Nature 501:373–379. https://doi.org/10.1038/nature12517
Larsson M, Sawada K, Morland C et al (2012) Functional and anatomical identification of a vesicular transporter mediating neuronal ATP release. Cereb Cortex 22:1203–1214. https://doi.org/10.1093/cercor/bhr203
Lavenex P, Lavenex PB, Bennett JL, Amaral DG (2009) Postmortem changes in the neuroanatomical characteristics of the primate brain: hippocampal formation. J Comp Neurol 512:27–51. https://doi.org/10.1002/cne.21906
Lee YJ, Yan BC, Park JH et al (2013) Differences of calcium binding proteins immunoreactivities in the young hippocampal CA1 region from the adult following transient ischemic damage. J Neurol Sci 326:40–47. https://doi.org/10.1016/j.jns.2012.12.026
Leitner DF, Connor JR (2012) Functional roles of transferrin in the brain. Biochim Biophys Acta 1820:393–402. https://doi.org/10.1016/j.bbagen.2011.10.016
Levesque JC, Parent A (2005) GABAergic interneurons in human subthalamic nucleus. Mov Disord 20:574–584. https://doi.org/10.1002/mds.20374
Li Z, Chen-Roetling J, Regan RF (2009) Increasing expression of H- or L-ferritin protects cortical astrocytes from hemin toxicity. Free Radic Res 43:613–621. https://doi.org/10.1080/10715760902942808
Mahad DJ, Ziabreva I, Campbell G et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161–1174. https://doi.org/10.1093/brain/awp046
Mallet N, Micklem BR, Henny P et al (2012) Dichotomous organization of the external globus pallidus. Neuron 74:1075–1086. https://doi.org/10.1016/j.neuron.2012.04.027
Mastroberardino PG, Hoffman EK, Horowitz MP et al (2009) A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson’s disease. Neurobiol Dis 34:417–431. https://doi.org/10.1016/j.nbd.2009.02.009
Mori S, Takino T, Yamada H, Sano Y (1985) Immunohistochemical demonstration of serotonin nerve fibers in the subthalamic nucleus of the rat, cat and monkey. Neurosci Lett 62:305–309
Morrow BA, Roth RH, Redmond DE Jr et al (2007) Apoptotic natural cell death in developing primate dopamine midbrain neurons occurs during a restricted period in the second trimester of gestation. Exp Neurol 204:802–807. https://doi.org/10.1016/j.expneurol.2007.01.009
Mulcahy P, O’Doherty A, Paucard A et al (2012) Development and characterisation of a novel rat model of Parkinson’s disease induced by sequential intranigral administration of AAV-alpha-synuclein and the pesticide, rotenone. Neuroscience 203:170–179. https://doi.org/10.1016/j.neuroscience.2011.12.011
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917
Nair R, Lauks J, Jung S et al (2013) Neurobeachin regulates neurotransmitter receptor trafficking to synapses. J Cell Biol 200:61–80. https://doi.org/10.1083/jcb.201207113
Nauta HJ, Cole M (1978) Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat. J Comp Neurol 180:1–16. https://doi.org/10.1002/cne.901800102
Parent A, Fortin M, Cote PY, Cicchetti F (1996) Calcium-binding proteins in primate basal ganglia. Neurosci Res 25:309–334
Parent M, Wallman MJ, Gagnon D, Parent A (2011) Serotonin innervation of basal ganglia in monkeys and humans. J Chem Neuroanat 41:256–265. https://doi.org/10.1016/j.jchemneu.2011.04.005
Park H-J, Kim CH, Park ES et al (2013) Increased GABA-A receptor binding and reduced connectivity at the motor cortex in children with hemiplegic cerebral palsy: a multimodal investigation using 18F-fluoroflumazenil PET, immunohistochemistry, and MR imaging. J Nucl Med 54:1263–1269. https://doi.org/10.2967/jnumed.112.117358
Perez RG, Waymire JC, Lin E et al (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090–3099
Péron J, Frühholz S, Vérin M, Grandjean D (2013) Subthalamic nucleus: a key structure for emotional component synchronization in humans. Neurosci Biobehav Rev 37:358–373. https://doi.org/10.1016/j.neubiorev.2013.01.001
Purushothuman S, Marotte L, Stowe S et al (2013) The response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model. PLoS One 8:e59740. https://doi.org/10.1371/journal.pone.0059740
Raadsheer FC, Sluiter AA, Ravid R et al (1993) Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 615:50–62
Ramsey IS, DeFelice LJ (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J Biol Chem 277:14475–14482. https://doi.org/10.1074/jbc.M110783200
Ribic A, Zhang M, Schlumbohm C et al (2010) Neuronal MHC class I molecules are involved in excitatory synaptic transmission at the hippocampal mossy fiber synapses of marmoset monkeys. Cell Mol Neurobiol 30:827–839. https://doi.org/10.1007/s10571-010-9510-3
Rothmond DA, Weickert CS, Webster MJ (2012) Developmental changes in human dopamine neurotransmission: cortical receptors and terminators. BMC Neurosci 13:18. https://doi.org/10.1186/1471-2202-13-18
Sager TN, Hansen AJ, Laursen H (2000) Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion. J Cereb Blood Flow Metab 20:780–788. https://doi.org/10.1097/00004647-200005000-00004
Sareen D, Ebert AD, Heins BM et al (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One 7:e39113. https://doi.org/10.1371/journal.pone.0039113
Saunders GC, Horigan V, Tout AC, Windl O (2007) Identification of a proteinase K resistant protein for use as an internal positive control marker in PrP Western blotting. Res Vet Sci 83:157–164. https://doi.org/10.1016/j.rvsc.2007.01.001
Schiffmann SN, Cheron G, Lohof A et al (1999) Impaired motor coordination and Purkinje cell excitability in mice lacking calretinin. Proc Natl Acad Sci USA 96:5257–5262
Schwarz G (1978) Estimating the dimension of a model. Ann Stat 6:461–464. https://doi.org/10.1214/aos/1176344136
Sengupta R, Burbassi S, Shimizu S et al (2009) Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR92-mediated survival signaling in neurons. J Neurosci 29:2534–2544. https://doi.org/10.1523/JNEUROSCI.5865-08.2009
Seo S, Leitch B (2014) Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy. Epilepsia 55:224–232. https://doi.org/10.1111/epi.12500
Serafeim A, Grafton G, Chamba A et al (2002) 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99:2545–2553
Shi SR, Cote RJ, Taylor CR (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45:327–343
Smith Y, Hazrati LN, Parent A (1990) Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 294:306–323. https://doi.org/10.1002/cne.902940213
Storn R, Price K (1997) Differential evolution—a simple and efficient heuristic for global optimization over continuous spaces. J Glob Optim 11:341–359. https://doi.org/10.1023/A:1008202821328
Sun C, Zhang L, Chen G (2013) An unexpected role of neuroligin-2 in regulating KCC2 and GABA functional switch. Mol Brain 6:23. https://doi.org/10.1186/1756-6606-6-23
Szeliski R (2010) Computer vision: algorithms and applications. Springer, New York
Takamori S, Rhee JS, Rosenmund C, Jahn R (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407:189–194. https://doi.org/10.1038/35025070
Temel Y, Blokland A, Steinbusch HWM, Visser-Vandewalle V (2005) The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 76:393–413. https://doi.org/10.1016/j.pneurobio.2005.09.005
Ten Kulve JS, Van Bloemendaal L, Balesar R et al (2016) Decreased hypothalamic glucagon-like peptide-1 receptor expression in type 2 diabetes patients. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-3291
Thévenaz P, Ruttimann UE, Unser M (1998) A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 7:27–41
Thomsen MS, Hay-Schmidt A, Hansen HH, Mikkelsen JD (2010) Distinct neural pathways mediate alpha7 nicotinic acetylcholine receptor-dependent activation of the forebrain. Cereb Cortex 20:2092–2102. https://doi.org/10.1093/cercor/bhp283
Van den Haute C, Spittaels K, Van Dorpe J et al (2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis 8:32–44. https://doi.org/10.1006/nbdi.2000.0333
van der Beek EM, Pool CW, van Eerdenburg FJ et al (1992) Fc-mediated nonspecific staining of the porcine brain with rabbit antisera in immunocytochemistry is prevented by pre-incubation of the sera with proteins A and G. J Histochem Cytochem 40:1731–1739
Van der Gucht E, Jacobs S, Kaneko T et al (2003) Distribution and morphological characterization of phosphate-activated glutaminase-immunoreactive neurons in cat visual cortex. Brain Res 988:29–42
van Vliet EA, Aronica E, Redeker S et al (2009) Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 50:422–433. https://doi.org/10.1111/j.1528-1167.2008.01727.x
Veeranna Kaji T, Boland B et al (2004) Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer’s disease. Am J Pathol 165:795–805. https://doi.org/10.1016/S0002-9440(10)63342-1
Vidal R, Miravalle L, Gao X et al (2008) Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J Neurosci 28:60–67. https://doi.org/10.1523/JNEUROSCI.3962-07.2008
Vymazal J, Urgosík D, Bulte JW (2000) Differentiation between hemosiderin- and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging. Cell Mol Biol (Noisy-le-grand) 46:835–842
Wagenmakers E-J, Farrell S (2004) AIC model selection using akaike weights. Psychon Bull Rev 11:192–196. https://doi.org/10.3758/BF03206482
Weigum SE, Garcia DM, Raabe TD et al (2003) Discrete nuclear structures in actively growing neuroblastoma cells are revealed by antibodies raised against phosphorylated neurofilament proteins. BMC Neurosci 4:6
Zander JF, Munster-Wandowski A, Brunk I et al (2010) Synaptic and vesicular coexistence of VGLUT and VGAT in selected excitatory and inhibitory synapses. J Neurosci 30:7634–7645. https://doi.org/10.1523/JNEUROSCI.0141-10.2010
Zawadzka M, Rivers LE, Fancy SPJ et al (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6:578–590. https://doi.org/10.1016/j.stem.2010.04.002
Zhou J, Nannapaneni N, Shore S (2007) Vessicular glutamate transporters 1 and 2 are differentially associated with auditory nerve and spinal trigeminal inputs to the cochlear nucleus. J Comp Neurol 500:777–787. https://doi.org/10.1002/cne.21208
Zhou C, Huang Z, Ding L et al (2013) Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome. J Biol Chem 288:21458–21472. https://doi.org/10.1074/jbc.M112.444372
Acknowledgements
The authors thank Dr. P-L. Bazin for helpful discussion about this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical standards
All tissues were obtained with consent in accordance with BrainNet Europe’s Code of Conduct for brain banking (Klioueva et al. 2015), and in compliance with the Dutch Burial and Cremation act. The authors’ research was supported by independent research grants: an ERC grant from the European Research Council (B.U.F.), a Vidi grant from the Dutch Organization for Scientific Research (B.U.F.), a grant by the Dutch Brain Foundation (B.U.F. and A.A.), and the Stichting Internationaal Parkinson Fonds (B.U.F. and A.A.).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anneke Alkemade, Gilles de Hollander and Steven Miletic contributed equally.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Alkemade, A., de Hollander, G., Miletic, S. et al. The functional microscopic neuroanatomy of the human subthalamic nucleus. Brain Struct Funct 224, 3213–3227 (2019). https://doi.org/10.1007/s00429-019-01960-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-019-01960-3